Skip to content

Clinical trials

Withdrawn Observational Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Observational Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20131
20161
20181
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre hospitalier de l'Université de Montréal (CHUM)1
Duke University1
Jonsson Comprehensive Cancer Center1
Maastricht Radiation Oncology1
National Cancer Institute (NCI)1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
University Health Network, Toronto1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma8
Astrocytoma3
Glioma3
Brain Neoplasms1
Ependymoma1
Hyperglycemia1
Neoplasms1
Neuroectodermal Tumors, Primitive1
Oligodendroglioma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.